# HSV Cure Research 2026: New Herpes Treatments, Vaccines, and Clinical Trials
 |
| HSV Cure Research 2026: New Herpes Treatments, Vaccines & Clinical Trials |
**Simple answer: There's no cure for herpes even in 2026**, but some unprecedented progress has been made this year. A new drug called **Pritelivir** has outperformed conventional treatments in Phase 3 trials, and drugs like **Adibelivir** are showing the potential to even inactivate dormant viruses. Here's a complete breakdown of the most important research and future directions of 2026.
# ## Biggest Breakthrough of 2026: Pritelivir Phase 3 Trial
**Pritelivir** is a new class of drug called **Helicase-Primase Inhibitors (HPIs). It blocks a different step in the virus's DNA replication and is also effective against **Acyclovir-resistant viruses**.
**PRIOH-1 Phase 3 Trial Results (2026):**
This trial was conducted in immunocompromised patients who had not responded to conventional treatment. 101 patients were randomized to Pritelivir or conventional treatment:
| Scale | Pritelivir | Conventional Treatment |
| :--- | :--- | :--- |
| **Wound Healing (28 Days)** | **62.7%** | 34.0% |
| **Drug Discontinuation Rate** | **2.0%** | 20.0% |
| **Kidney Problems** | **Less** | More |
Pritelivir healed wounds in **28.4% more patients** (p=0.0047), which is statistically significant. This drug is taken orally and has been prioritized in the FDA's New Drug Application (NDA) review.
In a separate case report, a patient with herpes encephalitis (a brain infection) who was not responding to conventional treatment began to show improvement within four days after receiving Pritelivir. Researchers found that the drug crosses the blood-brain barrier and reaches sufficient concentrations in the CSF.
# New Generation Drugs: Adibelivir and Other HPIs
In addition to Pritelivir, several other HPI drugs are in various stages of development:
- Adibelivir (IM-250): This drug has shown the potential to prevent the reactivation of dormant HSV-1 and HSV-2 viruses in preclinical studies. It also provides synergistic effects when combined with acyclovir.
- **HN0037:** This drug, developed in China, is in Phase 2 trials and has shown results in reducing the duration of genital herpes outbreaks by approximately 50%.
- **ABI-5366/GS-5366:** This is a **long-acting** drug that can be taken **once a month**, which could significantly simplify treatment.
## Vaccine Research: New Understanding and New Hope
An important scientific breakthrough in the field of herpes vaccines was made in 2026. According to a review published in *Current Opinion in Infectious Diseases*, **neutralizing antibodies alone are not enough**. Previous vaccine failures have shown that an effective vaccine requires both **polyfunctional antibodies and a cellular immune response**. This understanding is now providing new directions for vaccine design.
**mRNA-1608 therapeutic vaccine:** This vaccine from Moderna is for people who already have genital herpes. Its **Phase 1/2 trial** has been completed, and results are expected to be published in 2026.
**ARP02 mRNA vaccine:** This vaccine, developed in China, entered clinical trials in **July 2026**. It is being tested on adults who experience **at least 3 outbreaks of genital herpes a year**.
## HSV-1 now the leading cause of genital herpes
Research from 2026 highlights a significant shift: **HSV-1 now causes more than half of new genital herpes infections worldwide**. HSV-2 was previously considered the main cause of genital herpes, but this shift is due to the increasing prevalence of oral sex. This means that the terms "oral herpes" and "genital herpes" should now be used based on the location of infection, not the type of virus.
## Conclusion
Has a cure for herpes been found? No. But the prospects for treatment in 2026 have dramatically changed. Pritelivir has shown nearly twice the effectiveness of conventional treatments in Phase 3 trials and could be the first new treatment for acyclovir-resistant herpes in decades. Drugs like adebelivir are showing the ability to target dormant viruses, which could be a major step towards a permanent cure in the future. Until then, herpes can be effectively managed with the right treatment and precautions.